IRIS
ALBERTELLI, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.952
AS - Asia 1.003
NA - Nord America 889
Continente sconosciuto - Info sul continente non disponibili 223
SA - Sud America 94
AF - Africa 15
OC - Oceania 2
Totale 10.178
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.807
US - Stati Uniti d'America 830
SG - Singapore 351
CN - Cina 256
VN - Vietnam 166
BD - Bangladesh 136
BR - Brasile 62
FR - Francia 62
CA - Canada 27
HK - Hong Kong 26
AR - Argentina 14
DE - Germania 13
GB - Regno Unito 12
MX - Messico 12
FI - Finlandia 10
ID - Indonesia 9
JP - Giappone 9
JM - Giamaica 8
NL - Olanda 7
IE - Irlanda 6
IN - India 6
IQ - Iraq 6
TR - Turchia 6
ZA - Sudafrica 6
CH - Svizzera 5
CO - Colombia 4
EC - Ecuador 4
PK - Pakistan 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
ES - Italia 3
JO - Giordania 3
LB - Libano 3
OM - Oman 3
PH - Filippine 3
PL - Polonia 3
RU - Federazione Russa 3
SE - Svezia 3
TH - Thailandia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
HN - Honduras 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
RO - Romania 2
TN - Tunisia 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KW - Kuwait 1
LC - Santa Lucia 1
LV - Lettonia 1
MA - Marocco 1
MM - Myanmar 1
MQ - Martinica 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
WS - Samoa 1
Totale 9.955
Salva come PNG Salva come JPEG
Città #
Genova 3.658
Genoa 2.697
Vado Ligure 709
Rapallo 595
San Jose 216
Singapore 156
Ashburn 87
Lauterbourg 55
Beijing 52
Hanoi 39
Ho Chi Minh City 38
Council Bluffs 34
New York 32
Hong Kong 24
Los Angeles 23
Bordighera 19
Rome 19
Santa Clara 18
Chicago 14
Atlanta 13
Boardman 12
Frankfurt am Main 10
Haiphong 9
Milan 9
São Paulo 9
Buffalo 8
Helsinki 8
Mexico City 8
Orem 8
Tokyo 8
Da Nang 7
Toronto 7
Bologna 6
Charlotte 6
Dallas 6
Naples 6
Phoenix 6
Turin 6
Dublin 5
Florence 5
Kingston 5
Palermo 5
Zurich 5
Biên Hòa 4
Brooklyn 4
Cardiff 4
Curitiba 4
Des Moines 4
Houston 4
London 4
Mesa 4
Montreal 4
Shanghai 4
Amman 3
Amsterdam 3
Bangkok 3
Buenos Aires 3
Caracas 3
Chennai 3
Conway 3
Fayetteville 3
Memphis 3
Miami 3
Philadelphia 3
Quận Ba 3
Spokane 3
Thái Bình 3
Thái Nguyên 3
Trieste 3
Arlington 2
Baghdad 2
Bay Shore 2
Blumenau 2
Borgosesia 2
Brasília 2
Brescia 2
Brussels 2
Calgary 2
Cedar Rapids 2
Chaguanas 2
Chesapeake 2
City of London 2
Clarksville 2
Clinton 2
Corona 2
Denver 2
Des Plaines 2
Fort Lauderdale 2
Fort Myers 2
Fortaleza 2
Fredericksburg 2
Hammond 2
Hewitt 2
Johannesburg 2
Kapolei 2
Karachi 2
Karbala 2
Lappeenranta 2
North Hollywood 2
North Port 2
Totale 8.812
Salva come PNG Salva come JPEG
Nome #
Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients 243
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? 239
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 239
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 235
Current perspectives in obesity management: unraveling the impact of different therapy approach in real life obesity care 231
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study 224
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 214
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 213
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 211
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 187
"Present and future of immunotherapy in Neuroendocrine Tumors" 187
Emerging targets in pituitary adenomas: role of the CXCL12/CXCR4-R7 system 185
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 184
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 184
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors 180
KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment ? 179
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 179
One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients 173
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 172
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 171
Grade increases in gastroenteropancreatic neuroendocrine tumor metastases compared to the primary tumor 167
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures 162
Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible? 162
Doe4s biopsy reliably identify grade in gastro-entero-pancreatic neuroendocrine tumors? 161
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 161
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly 159
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 157
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies 153
Ectopic Cushing and other paraneoplastic syndromes in thoracic neuroendocrine tumors 152
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 151
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 148
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 140
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 139
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 138
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 135
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 134
A tool to predict survival in stage IV entero-pancreatic NEN 131
Does biopsy reliably identify grade in gastro-entero-pancreatic neuroendocrine tumors? 130
Ki-67 heterogeneity in gastroenteropancreatic neuroendocrine tumors 129
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 129
Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review 128
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 128
Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up 125
PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience 124
Hormone and Receptor Candidates for Target and Biotherapy of Neuroendocrine Tumors 124
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients 124
2-[18 F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study 117
An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report 113
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis 111
null 110
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose 109
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study 105
The effect of sodium restriction on iodine prophylaxis: a review 105
GH Replacement in the Elderly: Is It Worth It? 104
PRRT: identikit of the perfect patient 102
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 101
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 100
Primary hyperparathyroidism in patients with thyroid cancer: prevalence and prognosis in a retrospective monocentric study 97
Sodium Intake and Target Organ Damage in Hypertension-An Update about the Role of a Real Villain 88
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies 85
Erratum to: KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment? (Endocrine, (2017), 57, 3, (494-502), 10.1007/s12020-017-1364-8) 85
Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients 80
Nuove potenziali applicazioni degli analoghi della somatostatina 79
Possible protective role of metformin therapy on colonic polyps in acromegaly: An exploratory cross-sectional study 75
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders 71
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 70
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties 66
Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide 62
Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel 61
Rectal mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN): High grade evolution of a MANET? 61
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 58
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 57
null 57
Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask 46
Somatostatin receptor pathophysiology in the neuroendocrine system 24
Open issues on G3 neuroendocrine neoplasms: Back to the future 21
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study 20
The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience 17
Totale 10.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.672
article - articoli 34.086
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 586
Totale 69.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022661 37 22 39 80 12 70 24 154 52 70 21 80
2022/2023717 68 81 15 54 93 97 16 62 114 8 101 8
2023/2024528 26 69 6 66 39 96 39 30 13 31 45 68
2024/20251.784 51 96 56 139 239 180 205 287 51 89 178 213
2025/20263.124 354 115 414 242 343 216 370 117 247 243 196 267
2026/2027224 224 0 0 0 0 0 0 0 0 0 0 0
Totale 10.178